Indeed, it has been reported that TAs and quercetin may be therapeutically effective in AD by suppressing the expression of Th2 related cytokines, including TSLP and TARC, in Nc/Nga murine models showing pathologies such as AD [19,20]. Here, CCL17 is linked to Alzheimer disease.